Search

everythinglearnresearchcommunity

for

Search:↓

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Effective hirsutism treatment for women with PCOS should be personalized and may include lifestyle changes and medication.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

New drugs are improving treatment for hormone-related diseases in small pets.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Combining conventional and Chinese herbal medicine could help treat some skin and hormone-related diseases.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The treatment for alopecia areata with diphenylcyclopropenone was unsuccessful.

COC treatment improves hormone and metabolic levels in PCOS patients.

Hormones and daylight changes control when cashmere goats shed their hair.

New treatments are being explored to slow or reverse hereditary hair loss.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Alopecia in captive primates can be caused by many factors, so thorough testing is needed before blaming stress.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.